Human Flt-3 Ligand Protein (E. coli), premium grade

  • GMP version GMP-FLLH13 is now available for seamless transition.
ユーザーレビュー
製品番号/仕様
価格
数量
Premium grade lyophilized
FLL-H5115-20ug
$180.00
FLL-H5115-50ug
$425.00
FLL-H5115-1mg (200ug X 5)
$3560.00
GMP lyophilized
GMP-FLLH13-50ug
$840.00
GMP-FLLH13-1mg (50ug X 20)
$6425.00
GMP-FLLH13-10mg (50ug X 200)
$44975.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Features and Advantages

    1. Seamless Transition from Preclinical to Clinical: Same cell clone, process, and QC as GMP products.
    2. Enhanced Production Standards: AOF raw materials, pharma-grade excipients, Grade B+A (ISO 5) environment.
    3. Comprehensive Quality Control: Additional strict testing for process impurities, sterility, and mycoplasma.
    4. Cost-Effective Solution: GMP-comparable quality at an economical price for early development.
    5. Risk Mitigation: Enhanced safety through rigorous impurity control and comprehensive testing.
  • Synonyms

    FLT3LG, FL, FLT3L, Flt3 ligand

  • Source

    Human Flt-3 Ligand Protein (E. coli), premium grade (FLL-H5115) is expressed from E. coli cells. It contains AA Thr 27 - Ala 181 (Accession # P49771-1).

    Predicted N-terminus: Met

    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage.
    GMP-FLLH13 is the GMP version of this FLL-H5115. These two proteins display indistinguishable performance profiles, thereby ensuring a seamless transition for end users from early preclinical stage to later clinical phases.

    Request for sequence
  • Molecular Characterization

    Flt-3 Ligand Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries no "tag".

    The protein has a calculated MW of 17.7 kDa. The protein migrates as 17 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Host Cell Protein

    <0.5 ng/µg of protein tested by ELISA.

  • Host Cell DNA

    <0.02 ng/μg of protein tested by qPCR.

  • Sterility

    Negative

  • Mycoplasma

    Negative

  • Purity

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process
  • Quality Description

    ACRO's Research-grade products are suitable for a wide range of cell culture applications, particularly for research use in academic institutions. These products are sterilized by filtration, followed by lyophilization where applicable. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. Biological activity is calibrated against WHO/NIBSC standards when available.
    ACRO's Premium-grade (Pre-GMP) products are characterized by their high quality and enhanced safety profiles, making them ideal for early-stage discovery and manufacturing processes in cell therapy companies. A key advantage is their seamless transition to corresponding GMP-grade versions. Biological activity is calibrated against WHO/NIBSC standards when available. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. In addition, rigorous testing is conducted to ensure the absence of mycoplasma, HCD, and HCP, thereby guaranteeing product safety.

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    Flt-3 Ligand SDS-PAGE

    Human Flt-3 Ligand Protein (E. coli), premium grade on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    Flt-3 Ligand SEC-MALS

    The purity of Human Flt-3 Ligand Protein (E. coli), premium grade (Cat. No. FLL-H5115) is more than 95% and the molecular weight of this protein is around 35-50 kDa verified by SEC-MALS.

    Report
  • Bioactivity-CELL BASE

     Flt-3 Ligand CELL

    Human Flt-3 Ligand Protein (E. coli), premium grade (Cat. No. FLL-H5115) stimulates proliferation of OCI-AML5 cells. The specific activity of Human Flt-3 Ligand Protein (E. coli), premium grade is > 5.00 x 10^5 IU/mg, which is calibrated against human WHO-Flt3 Ligand International Standard (NIBSC code: 96/532) (QC tested).

    Protocol
  • Application Data

     Flt-3 Ligand APPLICATION DATA

    Human hematopoietic stem and progenitor cells (HSPCs) were expanded ex vivo for 9 days using a cytokine cocktail containing GMP Human SCF Protein (Cat. No. GMP-SCFH25), GMP Human Flt-3 Ligand Protein (E. coli) (Cat. No. GMP-FLLH13), and GMP Human Thrombopoietin Protein (Cat. No. GMP-THNH25). The cell growth curve and cell viability are analyzed by AO/PI staining. The results demonstrate that GMP Human Flt-3 Ligand Protein (E. coli) could support the rapid cell expansion and good cell viability of HSPCs, exhibiting performance comparable to that of Human Flt-3 Ligand Protein (E. coli), premium grade (Cat. No. FLL-H5115).

  •  Flt-3 Ligand APPLICATION DATA

    Human hematopoietic stem and progenitor cells (HSPCs) were cultured for 3 days in medium supplemented with GMP Human SCF Protein (Cat. No. GMP-SCFH25), GMP Human Flt-3 Ligand Protein (Cat. No. GMP-FLLH13), and GMP Human Thrombopoietin (TPO) Protein (Cat. No. GMP-THNH25). Flow cytometry was used to assess the expression of surface markers CD34 and CD45. The results demonstrate that GMP Human Flt-3 Ligand Protein (Cat. No. GMP-FLLH13) promoted HSPC proliferation to a similar extent as Human Flt-3 Ligand Protein (E. coli), premium grade (Cat. No. FLL-H5115).

ユーザーレビュー
コメントを投稿

バックグランド

FMS-like tyrosine kinase 3 ligand (Flt-3 Ligand) is also known as FL, Flt3L and FLT3LG, is an α-helical cytokine that promotes the differentiation of multiple hematopoietic cell lineages. FLT3LG is expressed as a noncovalentlylinked dimer by T cells and bone marrow and thymic fibroblasts. Each 36 kDa chain carries approximately 12 kDa of N- and O- linked carbohydrates. FLT3LG is structurally homologous to stem cell factor (SCF) and colony stimulating facor 1 (CSF-1). FLT3LG acts as a growth factor that increases the number of immune cells by activating the hematopoietic progenitors. It also induces the mobilization of the hematopoietic progenitors and stem cells in vivo which may help the system to kill cancer cells. FLT3LG induces the expansion of monocytes and immature dendritic cells as well as early B cell lineage differentiation. FLT3LG cooperates with IL2, IL6, IL7, and IL15 to induce NK cell development and with IL3, IL7 and IL11 to induce terminal B cell maturation. Animal studies also show FLT3LG to reduce the severity of experimentally induced allergic inflammation. FLT3LG is crucial for steady-state pDC and cDC development. A lack of FLT3L results in low levels of DCs.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Fms-related tyrosine kinase 3 ligand

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    2 詳細

  • 最新の開発ステージ:

    Phase 2 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8